Uric acid and high-residual platelet reactivity in patients treated with clopidogrel or ticagrelor
- 1 April 2016
- journal article
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 26 (4) , 352-358
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry studyThe Lancet, 2013
- Correlation of Platelet Reactivity and C-Reactive Protein Levels to Occurrence of Peri-Procedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the ARMYDA-CRP Study)The American Journal of Cardiology, 2013
- Chronic kidney disease is associated with increased platelet activation and poor response to antiplatelet therapyNephrology Dialysis Transplantation, 2013
- Contrast-Induced Nephropathy in Patients With ST Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary InterventionAngiology, 2012
- Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: A meta-analysis of 8 randomized trialsAtherosclerosis, 2012
- Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS‐PCI studyJournal of Thrombosis and Haemostasis, 2012
- New Insights into Uric Acid Effects on the Progression and Prognosis of Chronic Kidney DiseaseRenal Failure, 2012
- Prasugrel versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2007
- Xanthine Oxidoreductase Is an Endogenous Regulator of Cyclooxygenase-2Circulation Research, 2004
- Uric Acid Stimulates Monocyte Chemoattractant Protein-1 Production in Vascular Smooth Muscle Cells Via Mitogen-Activated Protein Kinase and Cyclooxygenase-2Hypertension, 2003